Republican U.S. Rep. Christopher Collins of New York has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades.
The charges were announced and the indictment unsealed in New York City on Wednesday.
The indictment charges Collins and two others, including the congressman’s son, with conspiracy, wire fraud and other counts.
Prosecutors say the charges relate to a scheme to gain insider information about a biotechnology company headquartered in Sydney, Australia, with offices in Auckland, New Zealand.
- B.C. First Nations explore if nuclear power could meet province’s electricity needs
- Hoekstra says Trump serious about tariff threat over wildfire smoke
- Ontario PC MPPs who spent big on hotels face questions as minister resigns
- 2 Saskatchewan research farms to stay open as province enters MOU with Ottawa
Get breaking National news
According to the indictment, the defendants tried to get early word on the results of tests by Innate Immunotherapeutics Limited.
The company developed a drug intended to treat Secondary Progressive Multiple Sclerosis.
Collins has denied any wrongdoing.
Comments
Want to discuss? Please read our Commenting Policy first.